Company · CIK 0001422142 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Whitehawk Therapeutics, Inc. · WHWK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:45 pm EDT | Scott M. GiacobelloCHIEF FINANCIAL OFFICER | 236,952 | — | — | 118,476 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:44 pm EDT | Bryan BallSee remarks | 183,266 | — | — | 91,633 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:43 pm EDT | David DornanChief Scientific Officer | 171,774 | — | — | 85,887 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:41 pm EDT | David James LennonCHIEF EXECUTIVE OFFICER, Director | 387,914 | — | — | 193,957 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:40 pm EDT | Margaret DuganChief Medical Officer | 162,500 | — | — | 81,250 | — | |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:07 pm EDT | David James LennonCHIEF EXECUTIVE OFFICER, Director | 387,914 | — | — | 193,957 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:07 pm EDT | Scott M. GiacobelloCHIEF FINANCIAL OFFICER | 236,952 | — | — | 118,476 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:06 pm EDT | Margaret DuganChief Medical Officer | 162,500 | — | — | 81,250 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:05 pm EDT | David DornanChief Scientific Officer | 171,774 | — | — | 85,887 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:05 pm EDT | Bryan BallSee remarks | 183,266 | — | — | 91,633 | — | amended |
| Sep 9, 2026 AForm 4 → | Sep 11, 4:04 pm EDT | Vijay K IyengarDirector | 76,080 | — | — | 76,080 | — |